IPCA LABORATORIES
|
The Current P/S Ratio of IPCA LABORATORIES is 5.10.
Share Price | ₹1,649.4 | Oct 17,2024 |
Market Cap | ₹41,844.0 Cr | |
Sales-TTM | ₹8,212.5 Cr | TTM-Consolidated Results |
Price/Sales | 5.10x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of IPCA LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹41,844.0 Cr] as on Oct 17,2024
(/) Sales [ ₹8,212.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.10x ]
Thus, for IPCA LABORATORIES , the investors are currently willing to pay '5.10 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of IPCA LABORATORIES !
The chart below summarizes the trend in P/S Ratio of IPCA LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of IPCA LABORATORIES
PS Ratio Performance Analysis for IPCA LABORATORIES
- IPCA LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 4.06x.
- IPCA LABORATORIES 's operated at median p/e ratio of 4.1x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, IPCA LABORATORIES 's p/e ratio peaked in Mar2022 at 4.64x.
- IPCA LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 3.31x.
How does IPCA LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
IPCA LABORATORIES | 8,212.5 | 5.10 | 41,844.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 49,208.8 | 9.22 | 453,486.0 |
CIPLA LTD | 26,139.1 | 4.81 | 125,852.0 |
DR REDDYS LABORATORIES LTD | 28,949.3 | 3.86 | 111,799.0 |
ZYDUS LIFESCIENCES LTD | 20,615.3 | 4.98 | 102,726.0 |
DIVIS LABORATORIES LTD | 8,185.0 | 19.71 | 161,321.0 |
MANKIND PHARMA LTD | 10,649.6 | 10.09 | 107,467.0 |
TORRENT PHARMACEUTICALS LTD | 10,996.0 | 10.45 | 114,943.0 |
LUPIN LTD | 20,797.1 | 4.77 | 99,304.7 |
AUROBINDO PHARMA LTD | 29,718.4 | 2.87 | 85,273.3 |
ABBOTT INDIA LTD | 5,927.5 | 10.19 | 60,382.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs IPCA LABORATORIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.87x |
Max industry PS | 19.71x |
Median industry PS | 5.10x |
Average industry PS | 7.82x |
You may also like the below Video Courses